Patient Name : MRS.

SUNITA NEPAL OtherLabRefNo :

Age/Gender : 35 Years/Female Collected : 25/Apr/2023 12:22PM
Visit No : ARDL114272 Received : 25/Apr/2023 12:32PM
Referred By : Dr.SELF Reported : 25/Apr/2023 12:59PM
Sample From : DOCTORS ON CALL PVT.LTD Report Status : Final Report

DEPARTMENT OF HAEMATOLOGY

CBC-COMPLETE BLOOD COUNT

Test Name Result Status Unit Bio. Ref. Range
Haemoglobin (HB) 10.12 L g/dl 12 - 16
Electrical impedance

Total Leukocyte Count (TLC) 9.97 N ths/ul 4.00 - 11.00

Electrical impedance

Differential Leukocyte Count (DLC)

Neutrophil 70 % 45 - 75
Microscopy

Lymphocyte 27 % 20 - 45
Microscopy

Monocyte 03 % 2-10
Microscopy

Eosinophil 00 % 1-6
Microscopy

Basophil 00 N % 0-2
Microscopy

Red Blood Cell Count 4.17 L 10^6/uL 4.5 - 5.8

Electrical impedance

PCV/Haematocrit 28 L % 38 - 50
Electrical impedance

MCV 67.1 L fL 83-101

Calculated

MCH 24.3 L pg 27-32

Calculated

MCHC 35.1 N g/dl 33.4 - 35.5

Calculated

Platelet Count 167 N ths/ul 150-450 ths/ul

Electrical impedance
Sample Type : Whole Blood EDTA

**Not under scope of Accreditation.

Page 1 of 5
 Patient Name : MRS. SUNITA NEPAL OtherLabRefNo :
Age/Gender : 35 Years/Female Collected : 25/Apr/2023 12:22PM
Visit No : ARDL114272 Received : 25/Apr/2023 12:32PM
Referred By : Dr.SELF Reported : 25/Apr/2023 01:40PM
Sample From : DOCTORS ON CALL PVT.LTD Report Status : Final Report

DEPARTMENT OF HAEMATOLOGY

ESR-ERYTHROCYTE SEDIMENTATION RATE

Test Name Result Status Unit Bio. Ref. Range
Erythrocyte Sedimentation Rate 32 H mm/h 0-20
Method:Westergren
Sample Type : Whole Blood EDTA
COMMENTS: ESR is an acute phase reactant that indicates the presence and intensity of an inflammatory process. It is never diagnostic
of a specific disease. It is used to monitor the course or response to treatment of certain diseases. Extremely high levels are found in
cases of malignancy, hematologic diseases, collagen disorders, and renal diseases. · Increased levels may indicate: Chronic renal failure
(e.g., nephritis, nephrosis), malignant diseases (e.g., multiple myeloma, Hodgkin disease, advanced Carcinomas), bacterial infections
(e.g., abdominal infections, acute pelvic inflammatory disease, syphilis, pneumonia), inflammatory diseases (e.g. temporal arteritis,
polymyalgia rheumatic, rheumatoid arthritis, rheumatic fever, systemic lupus erythematosus [SLE]), necrotic diseases (e.g., acute
myocardial infarction, necrotic tumor, gangrene of an extremity), diseases associated with increased proteins (e.g., hyperfibrinogenemia,
macroglobulinemia), and severe anemias (e.g., iron deficiency or B12 deficiency).
Falsely decreased levels may indicate Sickle cell anemia, spherocytosis, hypofibrinogenemia, or polycythemia vera.
*Under scope of Accreditation.

Page 2 of 5
Patient Name : MRS. SUNITA NEPAL OtherLabRefNo :
Age/Gender : 35 Years/Female Collected : 25/Apr/2023 12:22PM
Visit No : ARDL114272 Received : 25/Apr/2023 12:32PM
Referred By : Dr.SELF Reported : 25/Apr/2023 01:18PM
Sample From : DOCTORS ON CALL PVT.LTD Report Status : Final Report

DEPARTMENT OF BIOCHEMISTRY

FASTING BLOOD GLUCOSE

Test Name Result Status Unit Bio. Ref. Range
Fasting Blood Glucose 104.9 N mg/dl 60 - 110
Sample Type : Sodium Fluoride Plasma
INTERPRETATION:

Increased In

Diabetes Mellitus
Stress (e.g., emotion, burns, shock, anesthesia)
Acute pancreatitis
Chronic pancreatitis
Wernicke encephalopathy (vitamin B1 deficiency)
Effect of drugs (e.g. corticosteroids, estrogens, alcohol, phenytoin, thiazides)

Decreased In

Pancreatic disorders
Extrapancreatic tumors
Endocrine disorders
Malnutrition
Hypothalamic lesions
Alcoholism
Endocrine disorders

*Under scope of Accreditation.

Page 3 of 5
 Patient Name : MRS. SUNITA NEPAL OtherLabRefNo :
Age/Gender : 35 Years/Female Collected : 25/Apr/2023 12:22PM
Visit No : ARDL114272 Received : 25/Apr/2023 12:32PM
Referred By : Dr.SELF Reported : 25/Apr/2023 01:18PM
Sample From : DOCTORS ON CALL PVT.LTD Report Status : Final Report

DEPARTMENT OF BIOCHEMISTRY
CREATININE-SERUM
Test Name Result Status Unit Bio. Ref. Range
Creatinine 0.6 N mg/dl 0.6-1.4
Method: Enzymatic
Sample Type : Serum
*Under scope of Accreditation.
Increased In:

Diet: ingestion of creatinine (roast meat), Muscle disease: gigantism, acromegaly,

Impaired kidney function.

Decreased In:

Pregnancy: Normal value is 0.4-0.6 mg/dL. A value >0.8 mg/dL is abnormal and should alert the clinician to further diagnostic evaluation.
Creatinine secretion is inhibited by certain drugs (e.g., cimetidine, trimethoprim).

Page 4 of 5
Patient Name : MRS. SUNITA NEPAL OtherLabRefNo :
Age/Gender : 35 Years/Female Collected : 25/Apr/2023 12:22PM
Visit No : ARDL114272 Received : 25/Apr/2023 12:32PM
Referred By : Dr.SELF Reported : 25/Apr/2023 01:39PM
Sample From : DOCTORS ON CALL PVT.LTD Report Status : Final Report

DEPARTMENT OF HORMONE ASSAYS

TSH - SERUM
Test Name Result Status Unit Bio. Ref. Range
TSH- Thyroid Stimulating Hormones 0.018 L ulU/mL 0.35-5.50
(3rd Gen. )
CLIA
Sample Type : Serum

INTERPRETATION:-
Premature Infants 26-32 weeks,3-4 Days 0.8 - 6.9 mIU/L
Full Term Infants 4 Days 1.3 - 16.0 mIU/L
Newborns : TSH surges within the first 15-60 minutes of life
reaching peak levels between 25-60 uIU/ml at about
30 minutes. Values then decline rapidly and after one
week are within the adult normal range.
1 -11 Months 0.90 - 7.70 mIU/L
Prepubertal Children 0.60 - 5.50 mIU/L
Pubertal Children and Adults 0.35 - 5.50 mIU/L
Clinical Information :
Primary malfunction of the thyroid gland may result in excessive(hyper) or low(hypo) release of T3 or T4.In additional,as TSH
directly affect thyroid function,malfunction of the pituitary or the hypothalamus influences the thyroid gland activity.Disease in any
portion of the thyroid-pituitary-hypothalamus system may influence the level of T3 and T4 in the blood,in Primary
hypothyroidism,TSH levels are significantly elevated,while in secondary and tertiary hypothyrodism,TSH levels may be low.IN
addition,In Euthyroid sick Syndrom,multiple alterations in serum thyroid function test findings have been recognized.

*Under scope of Accreditation.

--------------- End Of Report ---------------

Page 5 of 5